²é¿´: 2504  |  »Ø¸´: 6
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

yining2008

Í­³æ (³õÈëÎÄ̳)

[½»Á÷] ÉϺ£Ò©Ã÷¿µµÂÕÐÆ¸

¾ßÌ幤×÷µØµã:
ÉϺ£ÆÖ¶«
н½ð:
5000+

ÁªÏµÓÊÏ䣺yining20081012@gmail.com
Óʼþ±êÌâ¸ñʽ£ºÐÕÃû£«Ó¦Æ¸£«ÕÐÆ¸¸Úλ
·Ç´Ë¸ñʽ²»ÓèÍÆ¼ö

ÕÐÆ¸¸Úλ: DNAºÏ³É¼¼ÊõÔ±
ÕÐÆ¸ÈËÊý: 1
¹¤×÷µØµã: ÉϺ£
¹¤×÷Ö°ÄÜ:  
ְλҪÇó: 1.·Ö×ÓÉúÎïѧÏà¹Ø×¨Òµ±¾¿ÆÒÔÉÏѧÀú£»
2.¾ßÓнÏÇ¿µÄʵÑé²Ù×÷ÄÜÁ¦ºÍÊìÁ·µÄ·Ö×ÓÉúÎïѧÏà¹ØÊµÑé²Ù×÷¼¼ÄÜ£¬¶Ô·Ö×ÓÉúÎïѧʵÑéÊÒ³£¹æÒÇÆ÷²Ù×÷ÊìÁ·£»
3.ÓÐDNAºÏ³É¡¢DNA¿Ë¡¡¢²âÐò¡¢PCR¼°ÉúÎïÐÅϢѧÏà¹Ø¾­ÑéÕßÓÅÏÈ£»
4.³Ïʵ¡¢¾´Òµ¡¢¹¤×÷»ý¼«Ö÷¶¯£¬¾ßÓнÏÇ¿µÄÔðÈÎÐÄÒÔ¼°ÍŶӺÏ×÷¾«Éñ¡£

ÕÐÆ¸¸Úλ: Senior Scientists in Preclinical Oncology
ÕÐÆ¸ÈËÊý: 1
¹¤×÷µØµã: ÉϺ£
¹¤×÷Ö°ÄÜ:  
ְλҪÇó: The rapidly expanding Oncology Business Unit of WuxiApptec has several openings for research scientists who have demonstrated expertise in any of the following areas: animal tumor models, cancer signal transduction pathways, oncology target validation, and mouse genetics. Skills in cell culture, Western blot, quantitative PCR, or immunostaining are essential, as are excellence in communication in English, including writing and spoken.

Qualifications:
Ph.D. in molecular biology, cell biology, genetics or any discipline relevant to cancer research

Experience: Academic or industrial postdoctoral training is expected but not required. Quality training with excellent track record however is essential in the selection process.

ÕÐÆ¸¸Úλ: Ö×ÁöÄ£ÐÍÑо¿Ô±
ÕÐÆ¸ÈËÊý: Èô¸É
¹¤×÷µØµã: ÉϺ£
¹¤×÷Ö°ÄÜ: 1. Establishment of novel orthotopic tumor models in mice with cancer cell lines or tumor fragments£»
2. Responsible for study design, execution, and drafting report for preclinical pharmacodynamical studies.
3. Communicate with the client and lead a team to execute multiple tasks independently.
1¡¢ÓÃÖ×Áöϸ°ûϵ»òÖ×Áö×éÖ¯½¨Á¢Ð¡ÊóԭλÖ×ÁöÄ£ÐÍ¡£
2¡¢¸ºÔð¿¹Ö×ÁöÒ©ÎïµÄ¶¯ÎïÌåÄÚҩЧѧÑо¿ÏîÄ¿¼Æ»®µÄд×÷¼°Ö´ÐУ¬¶ÀÁ¢Ó¦¶ÔÏîÄ¿½øÐÐÖеĸ÷ÖÖÈÎÎñ¡£
3¡¢Äܹ»ÊìÁ·µØ½øÐÐʵÑéÊý¾ÝµÄ´¦Àí¼°×«Ð´ÊµÑé·½°¸ºÍÑо¿±¨¸æµÈ¡£
  
ְλҪÇó: 1. Bachelor degree or above in pharmacology, biology, medicine or other related life science.
2. A thorough understanding in orthotopic tumor model and cancer pharmacology and one year above hand-on experience in animal surgery is required. Experience in orthotopic tumor model establishment is a plus.
3. Good English verbal and written communication skills, excellent interpersonal skills and collaborative spirits.
4. Self-motivated, detail-oriented and goal-oriented,
5. Good at literature reading and be able to creatively resolve different challenges.
6. Good at data analysis using Excel and other statistical software.
1¡¢ÉúÎïѧ¡¢Ò½Ñ§»òÏà¹Ø×¨ÒµÑ§Ê¿Ñ§Àú¡£.
2¡¢¶ÔԭλÖ×ÁöÄ£ÐͺÍÒ©ÀíѧÑо¿ÓÐÕûÌåµÄÀí½â£¬ÓÐÒ»ÄêÒÔÉÏСÊóÊÖÊõ¾­Ñé¡£ÓÐÖ×ÁöԭλģÐͽ¨Á¢µÄ¹¤×÷¾­ÑéÕßÓÅÏÈ¡£
3¡¢ÓÐÒ»¶¨µÄÓ¢ÓïÓïÑÔ¼°ÊéдÄÜÁ¦£¬È˼ʹµÍ¨ÄÜÁ¦Ç¿£¬ÓÐÍŶÓÒâʶºÍ¾«Éñ¡£
4¡¢¶Ô×Ô¼ºÑϸñÒªÇó£¬×¢ÖØÏ¸½Ú£¬¶Ô¼È¶¨µÄÄ¿±êÓÐÖ´ÖøµÄ×·Çó¡£
5¡¢ÎÄ×ÖÔĶÁÀí½âÄÜÁ¦Ç¿£¬Äܹ»´´ÔìÐԵؽâ¾ö²»Í¬µÄÎÊÌâ¡£
6¡¢ÄÜÊìÁ·µØÊ¹Óà Excel´¦ÀíÊý¾Ý£¬ÊìϤͳ¼Æ·ÖÎöÔ­ÀíºÍÏà¹ØµÄÈí¼þÓ¦Óá£


ÕÐÆ¸¸Úλ: Éñ¾­ÃâÒßѧÑо¿Ô±
ÕÐÆ¸ÈËÊý: Èô¸É
¹¤×÷µØµã: ÉϺ£
¹¤×÷Ö°ÄÜ: Research Scientists are to participate in drug discovery research and development programs. Scientists are responsible/assigned to develop, validate and execute in vitro assays/studies; to analyze and report data and results; to communicate with team members and/or clients (mostly in English). For experienced and qualified scientists with proven track record, she or he may be in charge of projects or studies as a lead. Scientists also play roles and take tasks necessary to department or company.
  
ְλҪÇó: 1¡¢B.S. or M.S. with solid knowledge and relevant skills and hands-on experience in biochemistry, molecular and cell biology.
2¡¢Specific knowledge and skills are desired in areas of GPCR/receptor and enzymatic assays/studies
3¡¢Able to analyze and report experimental data and results independently
4¡¢Good or sufficient oral/written communication English skills
5¡¢Able or willing to take multi-tasks and achieve goals in a fast pace working environments
6¡¢A good team player who is able to work and communicate effectively and efficiently with colleagues and/or clients.



ÕÐÆ¸¸Úλ: Ò©´ú¶¯Á¦Ñ§Ñо¿Ô±
ÕÐÆ¸ÈËÊý: Èô¸É
¹¤×÷µØµã: ÉϺ£
¹¤×÷Ö°ÄÜ: 1.PKÏîÄ¿¶¯ÎïformulationÅäÖÆ£¬ Éè¼Æ¸÷ÖÖ¶¯ÎÄö³ÝÀ࣬ȮºÍºï×ӵȣ©Ò©´ú¶¯Á¦Ñ§£¨ DMPK £©Ñо¿£»
2. ·ÖÎöÕûÀíÁÙ´²Ç°Ò©´ú¶¯Á¦Ñ§£¨ DMPK )ʵÑéÊý¾Ý
3.Á˽â¸÷ÖÖÌåÍâʵÑ飻
4. ÏòÉϼ¶¼°¿Í»§Ìṩҩ´ú¶¯Á¦Ñ§ÊµÑé·½°¸£¬ÏîÄ¿Íê³ÉºóÌá½»Ò©´ú¶¯Á¦Ñ§±¨¸æ£¬Óë¿Í»§¹µÍ¨£»
5.׫д²¢Ö´ÐÐÏàÓ¦µÄ±ê×¼²Ù×÷¹æ·¶¡£
  
ְλҪÇó: 1. ¾ßÓÐÒ½Ò©Ñз¢»òCRO¹«Ë¾Ò©´ú¶¯Á¦Ñ§Ñо¿¹¤×÷¾­Ñ飨1-2Ä꣩£»
2. ÉîÈëÀí½âÒ©´ú¶¯Á¦Ñ§£¨ DMPK £©ÀíÂÛ£»Ó¢ÎÄÊìÁ·
3. ÕÆÎÕÒ©ÎïÎüÊÕ¡¢·Ö²¼¡¢´úлºÍÏû³ýµÄ֪ʶ£»
4. ÊìÁ·ÕÆÎÕÊý¾Ý·ÖÎö֪ʶ£»
5. ÊìϤӢÎÄÎÄÏ×£¬ÕÆÎÕÏàӦѧ¿Æ½øÕ¹£¬
6. Á˽⶯ÎïʵÑé¼¼Êõ£¬ ¾ßÓзḻµÄÉúÎïÑùÆ··ÖÎö¾­Ñé¸üÓÅ£¨ HPLC, LC-MS/MS £¬ ELISA £© ¡£
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sety_xiang

½ð³æ (ÕýʽдÊÖ)

ÄúºÃ ÎÒӦƸDNAºÏ³É¼¼ÊõÔ± ¼òÀú·¢ÖÁÄúÓÊÏä Çë²éÊÕ
°ÑÓÐÏÞµÄÉúÃüͶÈëµ½ÎÞÏÞµÄ×öʵÑéÖС«¡«£¡
3Â¥2011-08-29 15:13:47
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 7 ¸ö»Ø´ð

ÉúÎïת»¯Ñ§

Òø³æ (СÓÐÃûÆø)

ÄúºÃ ÎÒӦƸ Ò©´ú¶¯Á¦Ñ§Ñо¿Ô±¼òÀú·¢ÖÁÄúÓÊÏä Çë²éÊÕ
4Â¥2011-08-29 22:15:09
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wwddjj

ľ³æ (СÓÐÃûÆø)

ÄãºÃ£¡ÎÒÒѾ­½«¼òÀú·¢ËÍÖÁÄãÓÊÏ䣬Çë²éÊÕ
oh,mygod!
6Â¥2011-09-10 15:22:14
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xull19860419

Í­³æ (ÕýʽдÊÖ)

ÄúºÃ£¡ÎÒӦƸҩ´ú¶¯Á¦Ñ§Ñо¿Ô±£¬¼òÀú·¢ÖÁÄúÓÊÏä £¬·Ç³£¸Ðл
7Â¥2011-10-11 23:06:17
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 265Çóµ÷¼Á +8 ÁºÁºÐ£Ð£ 2026-03-17 8/400 2026-03-20 14:40 by 27µÀ¿ÆÌØ
[¿¼ÑÐ] 295¸´ÊÔµ÷¼Á +7 ¼òľChuFront 2026-03-19 7/350 2026-03-20 14:11 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ£¬327·Ö£¬²ÄÁÏÓ뻯¹¤085600 +5 Ncdx123456 2026-03-19 5/250 2026-03-20 11:15 by wangy0907
[¿¼ÑÐ] 081700»¯¹¤Ñ§Ë¶µ÷¼Á +3 ¡¾1¡¿ 2026-03-16 3/150 2026-03-19 23:40 by edmund7
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +10 ÄÝÄÝninicgb 2026-03-15 14/700 2026-03-19 22:59 by ѧԱ8dgXkO
[¿¼ÑÐ] Áº³ÉΰÀÏʦ¿ÎÌâ×é»¶Ó­ÄãµÄ¼ÓÈë +9 һѼѼӴ 2026-03-14 11/550 2026-03-19 17:22 by £¡±¾°µÒ»´Î£¡
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +7 Ϊѧ666 2026-03-16 7/350 2026-03-19 14:48 by ¾¡Ë´Ò¢1
[½Ìʦ֮¼Ò] ½¹ÂÇ +9 Ë®±ùÔÂÔÂÒ°Íà 2026-03-13 13/650 2026-03-19 09:50 by otani
[¿¼ÑÐ] 295Çóµ÷¼Á +3 Ò»Ö¾Ô¸¾©Çø211 2026-03-18 5/250 2026-03-18 17:03 by zhaoqian0518
[¿¼ÑÐ] 085601ר˶£¬×Ü·Ö342Çóµ÷¼Á£¬µØÇø²»ÏÞ +5 share_joy 2026-03-16 5/250 2026-03-18 14:48 by haxia
[¿¼ÑÐ] 311Çóµ÷¼Á +6 26ÑÐ0 2026-03-15 6/300 2026-03-18 14:43 by haxia
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +3 ÄÝÄÝninicgb 2026-03-17 3/150 2026-03-18 10:29 by macy2011
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +3 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 3/150 2026-03-18 10:12 by macy2011
[¿¼ÑÐ] ¿¼Ñл¯Ñ§Ñ§Ë¶µ÷¼Á£¬Ò»Ö¾Ô¸985 +4 ÕÅvvvv 2026-03-15 6/300 2026-03-17 17:15 by ruiyingmiao
[¿¼ÑÐ] 308Çóµ÷¼Á +4 ÊÇLupa°¡ 2026-03-16 4/200 2026-03-17 17:12 by ruiyingmiao
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] 070300»¯Ñ§Ñ§Ë¶Çóµ÷¼Á +6 Ì«Ïë½ø²½ÁË0608 2026-03-16 6/300 2026-03-16 16:13 by kykm678
[¿¼ÑÐ] 070303 ×Ü·Ö349Çóµ÷¼Á +3 LJY9966 2026-03-15 5/250 2026-03-16 14:24 by xwxstudy
[¿¼ÑÐ] 326Çóµ÷¼Á +3 mlpqaz03 2026-03-15 3/150 2026-03-16 07:33 by Iveryant
[¿¼ÑÐ] Öпƴó²ÄÁÏÓ뻯¹¤319Çóµ÷¼Á +3 ÃÏöβÄÁÏ 2026-03-14 3/150 2026-03-14 20:10 by ms629
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û